Abstract

CRISOL-DEZA, Diego André. COVID-19 and adult T cell leukemia-lymphoma: a deadly synergy. Medicentro Electrónica [online]. 2023, vol.27, n.3  Epub Sep 01, 2023. ISSN 1029-3043.

Adult T cell leukemia-lymphoma is a common malignancy with a poor prognosis in the elderly population. We present a 44-year-old woman from Ayacucho who was diagnosed with a lymphoma subtype of this disease and a human T-lymphotropic virus-I infection; she showed superior vena cava occlusive syndrome with systemic chemotherapy treatment under an adjusted-dose regimen with rituximab plus etoposide, prednisone, vincristine, cyclophosphamide and doxorubicin. Subsequently, she was admitted to the emergency service due to respiratory distress, dry cough, decreased consciousness, hipercalcemia, chest tomography with a heterogeneous consolidation pattern in both lungs and positive RT-PCR nasopharyngeal swab test for COVID-19. She received treatment with hydroxychloroquine, azithromycin, corticosteroids and ivermectin with a poor response, rapid deterioration and died later. Adult T cell leukemia-lymphoma at an early age is rare and is related to chronic infections such as strongyloides or tuberculosis, susceptible to COVID-19.

Keywords : coronavirus infections; human t-lymphotropic virus 1; lymphoma, t-cell; neoplasms.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )